Modulation of small conductance calcium-activated potassium (SK) channels: A new challenge in medicinal chemistry

Current Medicinal Chemistry

Volumn 10, Issue 8, 2003, Pages 625-647

  Liegeois J F ^a   Mercier, F ^a   Graulich, A ^a   Graulich Lorge, F ^a   Scuvee Moreau J ^a   Seutin, V ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Afterhyperpolarization; Neurons; Small conductance calcium activated potassium channels

Indexed keywords

ALPHA BUNGAROTOXIN; AMILORIDE; AMITRIPTYLINE; APAMIN; ATRACURIUM; ATROPINE; BENZIMIDAZOLE DERIVATIVE; BICUCULLINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CHARYBDOTOXIN; CLOTRIMAZOLE; CYCLOPHANE DERIVATIVE; DEQUALINIUM; IBERIOTOXIN; LAUDANOSINE; LEIUROTOXIN I; LIGAND; NEUROTENSIN; NICOTINE; PANCURONIUM; PAXILLINE; PEPTIDE DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; QUINOLINE DERIVATIVE; TITYUS TOXIN; TUBOCURARINE CHLORIDE; UCL 1684; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACTION POTENTIAL; AFTERHYPERPOLARIZATION; BASAL GANGLION; BRAIN REGION; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL MEMBRANE; CELL TYPE; CHEMICAL MODIFICATION; CLINICAL CHEMISTRY; COGNITION; COGNITIVE DEFECT; DEPRESSION; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; EMOTIONALITY; HUMAN; LIMBIC SYSTEM; LIVER DISEASE; MEMORY; MEMORY DISORDER; MODULATION; MOLECULAR CLONING; MOTOR PERFORMANCE; MYOPATHY; NERVE CELL EXCITABILITY; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; POTASSIUM CONDUCTANCE; QUATERNARY; REVIEW; RISK ASSESSMENT; SUBSTANTIA NIGRA;

ANIMALS; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; HUMANS; LIGANDS; NEURONS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS;

EID: 0037230389     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033457908     Document Type: Review

References (124)

1. Hille, B. Ion Channels of Excitable Membranes, Third Edition; Sinauer Associates, Inc.: Sunderland, Massachussets, 2001; pp 1-722.
2. Vergara, C.; Latorre, R.; Marrion, N.V.; Adelman, J.P. Curr. Opin. Neurobiol. 1998, 8, 321-329.
3. Blatz, A.L.; Magleby, K.L. Trends Neurosci. 1987, 10, 463-467.
4. Sah, P.; Faber, E.S.L. Prog. Neurobiol. 2002, 66, 345-353.
5. Jan, L Y.; Jan, Y.N. Annu. Rev. Neurosci. 1997, 20, 91-123.
6. Kohler, M.; Hirschberg, B.; Bond, C.T.; Kinzie, J.M.; Marrion, N.V.; Maylie, J.; Adelman, J.P. Science 1996, 273, 1709-1714.
7. Hugues, M.; Romey, G.; Duval, D.; Vincent, J.P.; Lazdunski, M. Proc. Natl. Acad. Sci. USA 1982, 79, 1308-1312.
8. Jensen, B.S.; Strobaek, D.; Olesen, S.P.; Christophersen, P. Curr. Drug Targets 2001, 2, 401-422.
9. Wulff, H.; Miller, M.J.; Hansel, W.; Grissmer, S.; Cahalan, M.D.; Chandy, K.G. Proc. Natl. Acad. Sci. USA 2000, 97, 8151-8156.
10. Keen, J.; Khawaled, R.; Farrens, D.L.; Neelands, T.R.; Rivard, A.; Bond, C.T.; Janowsky, A.; Fakler, B.; Adelman, J.P.; Maylie, J. J. Neurosci. 1999, 19, 8830-8838.
11. Xia, X.M.; Fakler, B.; Rivard, A.; Wayman, G.; Johnson-Pais, T.; Keen, J.; Ishii, T.M.; Hirschberg, B.; Bond, C.T.; Lutsenko, S.; Maylie, J.; Adelman, J.P. Nature 1998, 395, 503-507.
12. Schumacher, M.A.; Rivard, A.; Bachinger, H.P.; Adelman, J.P. Nature 2001, 410, 1120-1124.
13. Shmukler, B.E.; Bond, C.T.; Wilhelm, S.; Bruening-Wright, A.; Maylie, J.; Adelman, J.P.; Alper, S.L. Biochim. Biophys. Acta 2001, 1518, 36-46.
14. Pedarzani, P.; Mosbacher, J.; Rivard, A.; Cingolani, L.A.; Oliver, D.; Stocker, M.; Adelman, J.P.; Fakler, B. J.Biol.Chem. 2001, 276, 9762-9769.
15. Stocker, M.; Krause, M.; Pedarzani, P. Proc. Natl. Acad. Sci. USA 1999, 96, 4662-4667.
16. Shepard, P.D.; Bunney, B.S. Exp. Brain Res. 1991, 86, 141-150.
17. Seutin, V.; Johnson, S.W.; North, R.A. Brain Res. 1993, 630, 341-344.
18. Wolfart, J.; Neuhoff, H.; Franz, O.; Roeper, J. J. Neurosci. 2001, 21, 3443-3456.
19. Osmanovic, S.S.; Shefner, S.A.; Brodie, M.S. Brain Res. 1990, 530, 283-289.
20. Osmanovic, S.S.; Shefner, S.A. J. Physiol. 1993, 469, 89-109.
21. Faber, E.S.L.; Sah, P. J. Neurosci. 2002, 22, 1618-1628.
22. Pedarzani, P.; Kulik, A.; Muller, M.; Ballanyi, K.; Stocker, M. J. Physiol. 2000, 527, 283-290.
23. Bean, A.J.; Roth, R.H. J. Neurosci. 1991, 11, 2694-2702.
24. McCormick, D.A. Trends Neurosci. 1989, 12, 215-221.
25. Cangiano, L.; Wallen, P.; Grillner, S. J. Neurophysiol. 2002, 88, 288-299.
26. Prisco, S.; Natoli, S.; Bernardi, G.; Mercuri, N.B. Neuropharmacology 2002, 42, 289-296.
27. Cingolani, L.A.; Gymnopoulos, M.; Boccaccio, A.; Stocker, M.; Pedarzani, P. J. Neurosci. 2002, 22, 4456-4467.
28. Stocker, M.; Pedarzani, P. Mol. Cell. Neurosci. 2000, 15, 476-493.
29. Tacconi, S.; Carletti, R.; Bunnemann, B.; Plumpton, C.; Merlo Pich, E.; Terstappen, G.C. Neuroscience 2001, 102, 209-215.
30. Rimini, R.; Rimland, J.M.; Terstappen, G.C. Mol. Brain Res. 2000, 85, 218-220.
31. Messier, C.; Mourre, C.; Bontempi, B.; Sif, J.; Lazdunski, M.; Destrade, C. Brain Res. 1991, 551, 322-326.
32. Deschaux, O.; Bizot, J.C.; Goyffon, M. Neurosci. Lett. 1997, 222, 159-162.
33. Ikonen, S.; Riekkinen, P. Jr. Eur. J. Pharmacol. 1999, 382, 151-156.
34. Van der Staay, F.J.; Fanelli, R.J.; Blokland, A.; Schmidt, B.H. Neurosci. Biobehav. Rev. 1999, 23, 1087-1110.
35. Fournier, C.; Kourrich, S.; Soumireu-Mourat, B.; Mourre, C. Behav. Brain Res. 2001, 121, 81-93.
36. Habermann, E.; Cheng-Raude, D. Toxicon 1975, 13, 465-473.
37. Grunnet, M.; Jespersen, T.; Angelo, K.; Frokjaer-Jensen, C.; Klaerke, D.A.; Olesen, S.P.; Jensen, B.S. Neuropharmacology 2001, 40, 879-887.
38. Cao, Y.J.; Dreixler, J.C.; Couey, J.J.; Houamed, K.M. Eur. J. Pharmacol. 2002, 449, 47-54.
39. Scuvée-Moreau, J.; Liégeois, J.F.; Massotte, L.; Seutin, V. J. Pharmacol. Exp. Ther. 2002, 302, 1176-1183.
40. Seutin, V.; Massotte, L.; Liégeois, J.F.; Scuvée-Moreau, J. Soc. Neurosci. Abstr. 2002, 28, 304-305.
41. Steketee, J.D.; Kalivas, P.W. J. Pharmacol. Exp. Ther. 1990, 254, 711-719.
42. Meyer-Lindenberg, A.; Miletich, R.S.; Kohn, D.; Esposito, G.; Carson, R.E.; Quarantelli, M.; Weinberger, D.R.; Berman, K.F. Nature Neurosci. 2002, 5, 267-271.
43. Dror, V.; Shamir, E.; Ghanshani, S.; Kimhi, R.; Swartz, M.; Barak, Y.; Weizman, R.; Avivi, L.; Litmanovitch, T.; Fantino, E.; Kalman, K.; Jones, E.G.; Chandy, K.G.; Gargus, J.J.; Gutman, G.A.; Navon, R. Mol. Psychiatry 1999, 4, 254-260.
44. Tsai, M.T.; Shaw, C.K.; Hsiao, K.J.; Chen, C.H. Mol. Psychiatry 1999, 4, 271-273.
45. Antonarakis, S.E.; Blouin, J.L.; Lasseter, V.K.; Gehrig, C.; Radhakrishna, U.; Nestadt, G.; Housman, D.E.; Kazazian, H.H.; Kalman, K.; Gutman, G.; Fantino, E.; Chandy, K.G.; Gargus, J.J.; Pulver, A.E. Am. J. Med. Genet. 1999, 88, 348-351.
46. Bonnet-Brilhault, F.; Laurent, C.; Campion, D.; Thibaut, F.; Lafargue, C.; Charbonnier, F.; Deleuze, J.F.; Menard, J.F.; Jay, M.; Petit, M.; Frebourg, T.; Mallet, J. Eur. J. Hum. Genet. 1999, 7, 247-250.
47. Miller, M.J.; Rauer, H.; Tomita, H.; Gargus, J.J.; Gutman, G.A.; Cahalan, M.D.; Chandy, K.G. J. Biol. Chem. 2001, 276, 27753-27756.
48. Ritsner, M.; Modai, I.; Ziv, H.; Amir, S.; Halperin, T.; Weizman, R.; Navon, R. Biol. Psychiatry 2002, 51, 788-794.
49. Crow, T.J. Schizophr. Bull. 1985, 11, 471-485.
50. Andreasen, N.C. Schizophr. Bull. 1985, 11, 380-389.
51. Choi, D.W. Neuron 1988, 1, 623-634.
52. Grenhoff, J.; Aston-Jones, G.; Svensson, Th. Acta Physiol. Scand. 1986, 128, 351-358.
53. Pidoplichko, V.I.; Debiasi, M.; Williams, J.T.; Dani, J.A. Nature 1997, 390, 401-404.
54. Ross, G.W.; Petrovitch, H. Drugs Aging 2001, 18, 797-806.
55. Gorell, J.M.; Rybicki, B.A.; Johnson, C.C.; Peterson, E.L. Neurology 1999, 52, 115-119.
56. Baldessarini, R.J. Drugs and the Treatment of Psychiatric Disorders: Depression and Anxiety Disorders. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edition; Hardman, J.G.; Limbird, L.E.; Goodman Gilman, A. Eds. New York, USA, 2001; pp 447-484.
57. Willner, P. Int. Clin. Psychopharmacol. 1997, 12, S7-14.
58. Bond, C.T.; Sprengel, R.; Bissonnette, J.M.; Kaufmann, W.A.; Pribnow, D.; Neelands, T.R.; Storck, T.; Baetscher, M.; Jerecic, J.; Maylie, J.; Knaus, H.G.; Seeburg, P.H.; Adelman, J.P. Science 2000, 289, 1942-1946.
59. Carmeliet, E. Physiol. Rev. 1999, 79, 917-1017.
60. Schetz, J.A.; Anderson, P.A. Cardiovasc.Res. 1995, 30, 755-762.
61. Busse, R.; Edwards, G.; Feletou, M.; Fleming, I.; Vanhoutte, P.M.; Weston, A.H. Trends Pharmacol.Sci. 2002, 23, 374-380.
62. Doughty, J.M.; Plane, F.; Langton, P.D. Am. J. Physiol. 1999, 276, H1107-H1112
63. Marty, A.; Neher, E. J. Physiol. 1985, 367, 117-141.
64. Lara, B.; Zapater, P.; Montiel, C.; de la Fuente, M.T.; Martinez-Sierra, R.; Ballesta, J.J.; Gandia, L.; Garcia, A.G. Biochem. Pharmacol. 1995, 49, 1459-1468.
65. Montiel, C.; Lopez, M.G.; Sanchez-Garcia, P.; Maroto, R.; Zapater, P.; Garcia, A.G. J. Physiol. 1995, 486, 427-437.
66. Nagayama, T.; Koshika, T.; Hisa, H.; Kimura, T.; Satoh, S. Eur. J. Pharmacol. 1997, 327, 135-141.
67. Nagayama, T.; Fukushima, Y.; Yoshida, M.; Suzuki-Kusaba, M.; Hisa, H.; Kimura, T.; Satoh, S. Am. J. Physiol. 2000, 279, R448-R454
68. Hosseini, R.; Benton, D.C.H.; Dunn, P.M.; Jenkinson, D.H.; Moss, G.W.J. J. Physiol. 2001, 535, 323-334.
69. Castle, N.A.; Haylett, D.G.; Morgan, J.M.; Jenkinson, D.H. Eur. J. Pharmacol. 1993, 236, 201-207.
70. Barfod, E.T.; Moore, A.L.; Lidofsky, S.D. Am. J. Physiol. 2001, 280, C836-C842
71. Roman, R.; Feranchak, A.P.; Troetsch, M.; Dunkelberg, J.C.; Kilic, G.; Schlenker, T.; Schaak, J.; Fitz, G. Am. J. Physiol. 2002, 282, G116-G122
72. Pribnow, D.; Johnson-Pais, T.; Bond, C.T.; Keen, J.; Johnson, R.A.; Janowsky, A.; Silvia, C.; Thayer, M.; Maylie, J.; Adelman, J.P. Muscle Nerve 1999, 22, 742-750.
73. Neelands, T.R.; Herson, P.S.; Jacobson, D.; Adelman, J.P.; Maylie, J. J. Physiol. 2001, 536, 397-407.
74. Roncarati, R.; Di Chio, M.; Sava, A.; Terstappen, G.C.; Fumagalli, G. Neuroscience 2001, 104, 253-262.
75. Tse, A.; Hille, B. Science 1992, 255, 462-464.
76. Buckner, S.A.; Milicic, I.; Daza, A.V.; Coghlan, M.J.; Gopalakrishnan, M. Br. J. Pharmacol. 2002, 135, 639-648.
77. Herrera, G.M.; Nelson, M.T. J. Physiol. 2002, 541, 483-492.
78. Vincent, J.P.; Schweitz, H.; Lazdunski, M. Biochemistry 1975, 14, 2521-2525.
79. Granier, C.; Pedroso Muller, E.; Van Rietschoten, J. Eur. J. Biochem. 1978, 82, 293-299.
80. Habermann, E. Pharmacol.Ther. 1984, 25, 255-270.
81. Demonchaux, P.; Ganellin, C.R.; Dunn, P.M.; Haylett, D.G.; Jenkinson, D.H. Eur. J. Med. Chem. 1991, 26, 915-920.
82. Abia, A.; Lobaton, C.; Moreno, A.; Garcia-Sancho, J. Biochim. Biophys. Acta 1986, 856, 403-407.
83. Castle, N.A.; Strong, P.N. FEBS Lett. 1986, 209, 117-121.
84. Chicchi, G.G.; Gimenez-Gallego, G.; Ber, E.; Garcia, M.L.; Winquist, R.; Cascieri, M.A. J. Biol. Chem. 1988, 263, 10192-10197.
85. Auguste, P.; Hughes, M.; Grave, B.; Gesquieres, J.C.; Mes, P.; Tartar, A.; Romey, G.; Schweitz, H.; Lazdunski, M. J. Biol. Chem. 1990, 265, 4753-4759.
86. Zerrouk, H.; Mansuelle, P.; Benslimane, A.; Rochat, H.; Martin-Eauclaire, M.F. FEBS Lett. 1993, 320, 189-192.
87. Zerrouk, H.; Lavaba-Djerbari, F.; Fremont, V.; Meki, A.; Darbon, H.; Mansuelle, P.; Oughuideni, R.; Van Rietschoten, J.; Rochat, H.; Martin-Eauclaire, M.F. Int. J. Pept. Protein Res. 1996, 48, 514-521.
88. Shakkottai, V.G.; Regaya, I.; Wulff, H.; Fajloun, Z.; Tomita, H.; Fathallah, M.; Cahalan, M.D.; Gargus, J.J.; Sabatier, J.M.; Chandy, K.G. J. Biol. Chem. 2001, 276, 43145-43151.
89. Legros, C.; Oughuideni, R.; Darbon, H.; Rochat, H.; Bougis, P.E.; Martin-Eauclaire, M.F. FEBS Lett. 1996, 390, 81-84.
90. Lecomte, C.; Ferrat, G.; Fajloun, Z.; Van Rietschoten, J.; Rochat, H.; Martin-Eauclaire, M.F.; Darbon, H.; Sabatier, J.M. J. Peptide Res. 1999, 54, 369-376.
91. Blanc, E.; Lecomte, C.; Van Rietschoten, J.; Sabatier, J.M.; Darbon, H. Proteins 1997, 29, 359-369.
92. Nohmi, M.; Kuba, K. Brain Res. 1984, 301, 146-148.
93. Cook, N.S.; Haylett, D.G. J. Physiol. 1985, 358, 373-394.
94. Dunn, P.M. Eur. J. Pharmacol. 1994, 252, 189-194.
95. Galanakis, D.; Davis, C.A.; Del Rey Herrero, B.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. Bioorg. Med. Chem. Lett. 1995, 5, 559-562.
96. Galanakis, D.; Calder, J.A.D.; Ganellin, C.R.; Owen, C.S.; Dunn, P.M. J. Med. Chem. 1995, 38, 3536-3546.
97. Galanakis, D.; Davis, C.A.; Del Rey Herrero, B.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. J. Med Chem. 1995, 38, 595-606.
98. Galanakis, D.; Ganellin, C.R.; Dunn, P.M. J. Med. Chem. 1996, 39, 3592-3595.
99. Galanakis, D.; Davis, C.A.; Ganellin, C.R.; Dunn, P.M. J. Med. Chem. 1996, 39, 359-370.
100. Galanakis, D.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. Arch. Pharm. 1996, 329, 524-528.
101. Campos Rosa, J.; Galanakis, D.; Ganellin, C.R.; Dunn, P.M. J. Med. Chem. 1996, 39, 4247-4254.
102. Campos Rosa, J.; Beckmit-Hall, B.M.; Galanakis, D.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. Bioorg. Med. Chem. Lett. 1997, 7, 7-10.
103. Campos Rosa, J.; Galanakis, D.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. J. Med. Chem. 1998, 41, 2-5.
104. Campos Rosa, J.; Galanakis, D.; Piergentili, A.; Bhandari, K.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. J. Med. Chem. 2000, 43, 420-431.
105. Dunn, P.M. Eur. J. Pharmacol. 1999, 368, 119-123.
106. Chen, J.Q.; Galanakis, D.; Ganellin, C.R.; Dunn, P.M.; Jenkinson, D.H. J. Med. Chem. 2000, 43, 3478-3481.
107. Johnson, S.W.; Seutin, V. Neurosci. Lett. 1997, 231, 13-16.
108. Dinan, T.G.; Crunelli, V.; Kelly, J.S. Brain Res. 1987, 407, 159-162.
109. Kuo, C.C. Biophys. J. 1998, 75, 2845-2857.
110. Mathie, A.; Wooltorton, J.R.; Watkins, C.S. Gen.Pharmacol. 1998, 30, 13-24.
111. Dreixler, J.C.; Bian, J.T.; Cao, Y.J.; Roberts, M.T.; Roizen, J.D.; Houamed, K.M. Eur. J. Pharmacol. 2000, 401, 1-7.
112. Schohe-Loop, R.; Seidel, P.R.; Bullock, W.; Feurer, A.; Terstappen, G.C.; Schumacher, J.; Van der Staay, F.J.; Schmidt, B.; Fanelli, R.J.; Chouinard, G.; McCarthy, R.T. US Patent 5866562, 1999.
113. Schohe-Loop, R.; Seidel, P.R.; Bullock, W.; Feurer, A.; Terstappen, G.C.; Schumacher, J.; Van der Staay, F.J.; Schmidt, A.G.; Fanelli, R.J.; Chisholm, J.C.; Mac Carthy, R.T. US Patent 6174897B1, 2001.
114. Teuber, L.; Olesen, S.P.; Strøbæk, D.; Jensen, B.S.; Peters, D. Potassium channel blocking agents. PCT WO 00/01676, 2002.
115. Sah, P. Trends Neurosci. 1996, 19, 150-154.
116. Devor, D.C.; Singh, A.K.; Frizzell, R.A.; Bridges, R.J. Am. J. Physiol. 1996, 271, L775-L784
117. Jensen, B.S.; Strøbæk, D.; Christophersen, P.; Jorgensen, T.D.; Hansen, C.; Silahtaroglu, A.; Olesen, S.P.; Ahring, P.K. Am. J. Physiol. 1998, 275, C848-C856
118. Fanger, C.M.; Ghanshani, S.; Logsdon, N.J.; Rauer, H.; Kalman, K.; Zhou, J.; Beckingham, K.; Chandy, K.G.; Cahalan, M.D.; Aiyar, J. J. Biol. Chem. 1999, 274, 5746-5754.
119. Cao, Y.J.; Dreixler, J.C.; Roizen, J.D.; Roberts, M.T.; Houamed, K.M. J. Pharmacol. Exp. Ther. 2001, 296, 683-689.
120. Finlayson, K.; McLuckie, J.; Hern, J.; Aramori, I.; Olverman, H.J.; Kelly, J.S. Neuropharmacology 2001, 41, 341-350.
121. Galvez, A.; Gimenez-Gallego, G.; Reuben, J.P.; Roy-Contancin, L.; Feigenbaum, L.; Kaczorowski, G.J.; Garcia, M.L. J. Biol. Chem. 1990, 265, 11083-11090.
122. Shah, M.; Haylett, D.G. Br. J. Pharmacol. 2000, 129, 627-630.
123. Strobaek, D.; Jorgensen, T.D.; Christophersen, P.; Ahring, P.K.; Olesen, S.P. Br. J. Pharmacol. 2000, 129, 991-999.
124. Seutin, V.; Scuvée-Moreau, J.; Dresse, A. Neuropharmacology 1997, 36, 1653-1657.